Stay updated on Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.

Latest updates to the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe Record History page now shows revision v3.5.3, replacing the previous v3.5.2. It reflects a small update to the page's revision history rather than changes to the study content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded revision v3.5.2 to the history and removed revision v3.5.0.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the history section.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision: v3.4.2 added; earlier notices about government funding status and the v3.4.1 revision were removed.SummaryDifference0.8%

- Check94 days agoChange DetectedAdded a site-wide notice about government funding and NIH operations, and updated the record to Revision v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.